C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/1997
11/26/1997	EP0808361A1 Novel replication process
11/25/1997	US5691449 Respiratory syncytial virus vaccines
11/25/1997	US5691177 Lymphocytes and genetic vectors for treatment of cancer or autoimmune diseases
11/25/1997	US5691176 Recombinant adeno-associated virus vector packaging cells and methods for use
11/25/1997	US5691132 Method for inactivating pathogens in red cell compositions using quinacrine mustard
11/25/1997	US5690940 Low pathogencity PRRS live virus vaccines and methods of preparation thereof
11/25/1997	US5690937 Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
11/22/1997	CA2205078A1 Novel adenoviral vector for transferring human genes in vivo
11/20/1997	WO1997043431A1 Vehicle for the transport of molecular substances
11/20/1997	WO1997042972A1 Attenuated canine parvovirus vaccine
11/20/1997	WO1997035994A3 Cytochrome p450 transducing retroviral vectors
11/20/1997	CA2247392A1 Vehicle for the transport of molecular substances
11/19/1997	EP0807183A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
11/19/1997	EP0502146B1 MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEIN gE
11/19/1997	EP0469089B1 Generation of hybrid genes and proteins by virus-mediated recombination
11/18/1997	US5688688 Vector for expression of a polypeptide in a mammalian cell
11/18/1997	US5688675 In vitro packaging of adeno-associated virus DNA
11/18/1997	US5688513 Immunology with polypeptides against eimeria and coccidiosis
11/18/1997	US5688501 Treating infectious disease caused by bacteria by administering bacteriophages obtained by serial passage through circulatory system and selected to have longer half-life
11/13/1997	WO1997029195A3 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
11/13/1997	DE19618797A1 Vehikel zum Transport molekularer Substanz Vehicle for the transport of molecular substance
11/13/1997	DE19618787A1 Therapeutic device for regulating temp. of skin parts of human body
11/12/1997	EP0805877A1 Improved method of selecting specific bacteriophages
11/12/1997	EP0805868A1 Cells for the production of recombinant adenoviruses
11/12/1997	EP0805862A1 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
11/12/1997	EP0805854A1 Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens
11/12/1997	CN1164871A Insect viruses, sequences, insecticidal compositions and methods of use
11/12/1997	CN1164423A Application of bovine hepatitis B virus
11/11/1997	US5686287 Marek's disease virus vaccine
11/11/1997	US5686279 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
11/11/1997	US5686076 gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission
11/06/1997	WO1997041440A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
11/06/1997	WO1997041245A1 Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins
11/06/1997	WO1997040861A1 Biological material free of viral and molecular pathogens and a process for the production thereof
11/06/1997	WO1997024452A3 Toxic-protein expressing viruses and producer cell lines
11/06/1997	CA2253595A1 Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins
11/06/1997	CA2253300A1 Biological material free of viral and molecular pathogens and a process for the production thereof
11/06/1997	CA2252675A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
11/05/1997	EP0804602A1 Hsv viral vector
11/05/1997	EP0804571A1 Spider neurotoxins and method of producing the same
11/05/1997	EP0804547A1 Unique associated kaposi's sarcoma virus sequences and uses thereof
11/05/1997	EP0804458A1 Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
11/05/1997	EP0804233A1 Methods for the cultivation of infectious laryngotracheitis virus and egg drop syndrome virus
11/05/1997	EP0804232A1 Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome
11/05/1997	EP0804163A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof
11/05/1997	EP0804074A1 Treating red blood cell solutions with anti-viral agents
11/05/1997	CN1164258A Nucleotide sequences of HIV-10 type (or subtype) O retrovirus antigens
11/04/1997	US5683901 Method of producing RNA viruses from cDNA
11/04/1997	US5683865 Method for diagnosis of mystery swine disease
10/1997
10/30/1997	WO1997040180A1 Chicken embryo lethal orphan (celo) virus
10/30/1997	WO1997040166A2 Simian-human hav having a chimeric 2c protein
10/30/1997	WO1997040058A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997	WO1997035997A3 Recombinant pox virus encoding myelin protein for therapy
10/30/1997	CA2252835A1 Chicken embryo lethal orphan (celo) virus
10/30/1997	CA2252581A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997	CA2251832A1 Simian-human hav having a chimeric 2c protein
10/29/1997	EP0802983A2 Expression of urokinase plasminogen activator inhibitors
10/29/1997	EP0802980A1 Nucleic acid immunization using a virus-based infection/transfection system
10/29/1997	CN1163634A DNA Encoding human papillomavirus type 6 a
10/28/1997	US5681946 Precipitating polymers
10/28/1997	US5681746 Genetic engineering
10/28/1997	US5681734 Biological control agent
10/28/1997	US5681731 Adeno-associated virus transducing vector having cellular tropism of different parvovirus, comprising gene encoding capsid protein of said parvovirus, other exogenous genetic material
10/28/1997	US5681724 Parasitic helminth macrophage inhibitory factor nucleic acid molecules and uses thereof
10/23/1997	WO1997039134A1 Virus-like particle
10/23/1997	WO1997039119A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997	WO1997039118A1 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system
10/23/1997	WO1997039111A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections
10/23/1997	WO1997038666A2 Sulfur gasification power plant
10/23/1997	DE19615803A1 CELO-Virus CELO virus
10/23/1997	CA2251818A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997	CA2251724A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections
10/22/1997	EP0801678A1 Recombinant swinepox virus
10/21/1997	US5679551 Genetic engineering; insertion of genetic vector
10/21/1997	US5679510 Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support
10/21/1997	US5679348 Applying a local therapeutic or prophylactic vaccine for the eye comprising one or more recombinant hsv-1 glycoproteins
10/16/1997	WO1997038138A1 Attenuated respiratory syncytial virus
10/16/1997	WO1997038118A1 Defective viral vaccine particles obtained in vivo or ex vivo
10/16/1997	WO1997038094A1 Influenza virus replicated in mammalian cell culture and vaccine production
10/16/1997	WO1997038087A2 Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
10/16/1997	WO1997037686A1 Process for disintegrating nucleic acids and preparing biological products of guaranteed quality
10/16/1997	WO1997037676A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997	CA2250883A1 Attenuated respiratory syncytial virus
10/16/1997	CA2250835A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997	CA2250716A1 Influenza virus replicated in mammalian cell culture and vaccine production
10/15/1997	EP0800588A1 Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support
10/15/1997	CN1162338A Viable contaminant particle free adenoviruses, their preparation and use
10/15/1997	CN1162336A Identification of human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression
10/14/1997	US5677429 Vaccine
10/14/1997	US5677179 Respiratory system disorder
10/14/1997	US5677178 Cytopathic viruses for therapy and prophylaxis of neoplasia
10/14/1997	US5677158 In vitro packaging of adeno-associated virus DNA
10/14/1997	US5677147 HIV-2 virus variants
10/14/1997	US5677124 Nucleic acid encapsulated by bacteriophage protein
10/14/1997	US5676952 Genetic engineered vaccine
10/14/1997	US5676951 Bovine herpesvirus type 1 deletion mutants and vaccines
10/09/1997	WO1997037001A1 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
10/09/1997	WO1997037000A1 Animal cells and processes for the replication of influenza viruses
10/09/1997	WO1997036481A1 Design of novel highly efficient hiv based packaging systems for gene therapy
10/09/1997	WO1997032018A3 Hepatitis c virus ribozymes

1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 267